Invention Grant
US08859582B2 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
有权
双环杂环化合物作为蛋白酪氨酸激酶抑制剂
- Patent Title: Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
- Patent Title (中): 双环杂环化合物作为蛋白酪氨酸激酶抑制剂
-
Application No.: US13275752Application Date: 2011-10-18
-
Publication No.: US08859582B2Publication Date: 2014-10-14
- Inventor: Gordon Saxty , Valerio Berdini , Christopher William Murray , Charlotte Mary Griffiths-Jones , Emma Vickerstaffe , Gilbert Ebai Besong
- Applicant: Gordon Saxty , Valerio Berdini , Christopher William Murray , Charlotte Mary Griffiths-Jones , Emma Vickerstaffe , Gilbert Ebai Besong
- Applicant Address: GB Cambridge
- Assignee: Astex Therapeutics Limited
- Current Assignee: Astex Therapeutics Limited
- Current Assignee Address: GB Cambridge
- Agency: Heslin Rothenberg Farley & Mesiti P.C.
- Priority: GB0720038.9 20071012
- Main IPC: A01N43/42
- IPC: A01N43/42 ; A61K31/44 ; C07D513/02 ; C07D515/02 ; C07D471/04
Abstract:
The invention relates to new bicyclic heterocyclic derivative compounds of formula (I): wherein R1, q, A, B, X1, X2, X3, X4, X5 and R2 are as defined herein, to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Public/Granted literature
- US20120035152A1 BICYCLIC HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS Public/Granted day:2012-02-09
Information query
IPC分类:
